Epidermal growth factor receptor family members (EGFR and HEr2) are prognostic markers and potential therapeutic targets in prostate cancer

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [31] Plasma HER2 and EGFR levels are prognostic factors in patients with prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (1): : 4 - 4
  • [32] Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells
    Xu, H
    Yu, YJ
    Marciniak, D
    Rishi, AK
    Sarkar, FH
    Kucuk, O
    Majumdar, APN
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (03) : 435 - 442
  • [33] Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva
    Bartoletti, Michele
    Mazzeo, Roberta
    De Scordilli, Marco
    Del Fabro, Anna
    Vitale, Maria Grazia
    Bortot, Lucia
    Nicoloso, Milena Sabrina
    Corsetti, Serena
    Bonotto, Marta
    Scalone, Simona
    Giorda, Giorgio
    Sorio, Roberto
    Andreetta, Claudia
    Meacci, Maria Luisa
    De Vivo, Rocco
    Fasola, Gianpiero
    Sopracordevole, Francesco
    Puglisi, Fabio
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1672 - 1677
  • [34] Comparative Analysis of Evolutionarily Conserved Motifs of Epidermal Growth Factor Receptor 2 (HER2) Predicts Novel Potential Therapeutic Epitopes
    Deng, Xiaohong
    Zheng, Xuxu
    Yang, Huanming
    Moreira, Jose Manuel Afonso
    Brunner, Nils
    Christensen, Henrik
    PLOS ONE, 2014, 9 (09):
  • [35] Expression and co-expression of the Epidermal Growth Factor Receptor [EGFR] family members in invasive breast cancer
    El-Rehim, DMA
    Pinder, S
    Ellis, IO
    JOURNAL OF PATHOLOGY, 2004, 204 : 15A - 15A
  • [36] Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen
    Chae, Han Kyu
    Nam, Wook
    Kim, Han Gwun
    Lim, Sharon
    Noh, Byeong-Joo
    Kim, So Won
    Kang, Gil Hyun
    Park, Jong Yeon
    Eom, Dae-Woon
    Kim, Sung Jin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Prognostic and predictive significance of insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), and HER2 in metastatic colorectal cancer.
    Yamada, Y
    Goto, A
    Ura, T
    Yasui, H
    Kato, K
    Hamaguchi, T
    Muro, K
    Shimada, Y
    Shimoda, T
    Shirao, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 873S - 873S
  • [38] HER2 as a potential therapeutic target on quiescent prostate cancer cells
    Yumoto, Kenji
    Rashid, Jibraan
    Ibrahim, Kristina G.
    Zielske, Steven P.
    Wang, Yu
    Omi, Maiko
    Decker, Ann M.
    Jung, Younghun
    Sun, Dan
    Remmer, Henriette A.
    Mishina, Yuji
    Buttitta, Laura A.
    Taichman, Russell S.
    Cackowski, Frank C.
    TRANSLATIONAL ONCOLOGY, 2023, 31
  • [39] CTGF: A LIGAND OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR). OPENING NOVEL POTENTIAL THERAPEUTIC TARGETS FOR RENAL DISEASES.
    Rayego-Mateos, Sandra
    Rodrigues-Diez, Raquel
    Rodrigues-Diez, Raul R.
    Lavoz-Barria, Carolina
    Alique, Matilde
    Mas, Sebastian
    Pato, Janos
    Keri, Gyorgy
    Egido, Jesus
    Ortiz, Alberto
    Ruiz-Ortega, Marta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 9 - 9
  • [40] Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
    Jethwa, Megha
    Gangopadhyay, Aditi
    Saha, Achintya
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 11
12345